PULSE: Immune checkpoint inhibitor rechallenge: stepping on the gas again

December 15, 2021

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Target Audience

Pharmacist

Learning Objectives

Identify the role of checkpoint inhibitor immunotherapy in current oncology practice

Describe immune related adverse events and their management

Discuss the literature regarding immune checkpoint inhibitor rechallenge following immune related adverse events

Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Course opens: 
12/15/2021
Course expires: 
01/15/2022
Event starts: 
12/15/2021 - 1:00pm
Event ends: 
12/15/2021 - 2:00pm

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

UPMC Presbyterian
Pittsburgh, PA
United States

Diana Mansour, PharmD
PGY2 Oncology Pharmacy Resident
UPMC Shadyside and Hillman Cancer Center

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Please login or register to take this course.